Summary
Acorda Therapeutics is an American biotechnology company developing therapies for people with neurological disorders such as Parkinson's disease or multiple sclerosis.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Ron Cohen
CEO and President
Michael Gesser
CFO
Tierney Saccavino
Executive Vice President of Corporate Communications
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy